| 9039 |
Sakai Moving Service Co., Ltd.
|
Other |
|
Notice Regarding Partial Changes (Enhancement) to the Shareholder Benefit Program
|
Mar 6, 2026
|
| 9039 |
Sakai Moving Service Co., Ltd.
|
Earnings |
|
Announcement Regarding February 2026 Monthly Sales (Preliminary Figures)
|
Mar 6, 2026
|
| 4894 |
Quolips, Inc.
|
Strategy |
|
Acquisition of Conditional and Time-limited Manufacturing and Marketing Approval for Human (Allogeneic) iPS Cell-Derived Cardiomyocyte Sheet
|
Mar 6, 2026
|
| 3663 |
Celsys, Inc.
|
Earnings |
|
Announcement of Monthly Business Progress Report for February 2026
|
Mar 6, 2026
|
| 9663 |
Nagowa Co., Ltd.
|
Share Buyback |
|
Notice Regarding the Result of Treasury Stock Acquisition through ToSTNeT-3 and Completion of Treasury Stock Acquisition
|
Mar 6, 2026
|
| 6859 |
ESPEC Corporation
|
Share Buyback |
|
Notice Regarding the Status of Treasury Stock Acquisition (Acquisition of Treasury Stock Based on Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Mar 6, 2026
|
| 4506 |
Sumitomo Pharma Co., Ltd.
|
Strategy |
|
Announcement Regarding the Obtaining of Manufacturing and Marketing Approval in Japan for Allogeneic iPS Cell-Derived Dopaminergic Neural Progenitor Cell ‘Amsepre®’
|
Mar 6, 2026
|
| 4005 |
Sumitomo Chemical Company, Limited
|
Strategy |
|
Notice Regarding Approval for Manufacturing and Marketing of iPS Cell-Derived Product “Amshepli®” for Parkinson’s Disease Patients by Our Subsidiary
|
Mar 6, 2026
|
| 7860 |
Avex Inc.
|
M&A |
|
Notice Regarding Absorption-Type Merger (Simplified Merger) of a Wholly-Owned Subsidiary
|
Mar 5, 2026
|
| 4452 |
Kao Corporation
|
Other |
|
Notice Regarding Shareholders’ Request for Convening an Extraordinary General Meeting of Shareholders
|
Mar 5, 2026
|
| 3287 |
Hoshino Resorts REIT, Inc.
|
Earnings |
|
Notice on Portfolio Operational Performance (January 2026)
|
Mar 5, 2026
|
| 5262 |
Nippon Hume Co., Ltd.
|
Share Buyback |
|
Notice Regarding the Determination of Disposal Price and Offering Price
|
Mar 5, 2026
|
| 9697 |
Capcom Co., Ltd.
|
Personnel |
|
Notice Regarding Changes in Directors and Personnel Changes
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction) Partial Correction to “Financial Summary for the Third Quarter of the Fiscal Year Ending March 2024 [Japanese GAAP] (Consolidated)”
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction) Partial Correction to the “Financial Summary for the Fiscal Year Ending March 2024 [Japanese GAAP] (Consolidated)”
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction: Numerical Data Revision) Partial Correction of the “Financial Summary for the First Quarter of the Fiscal Year Ending March 2025 [Japanese GAAP] (Consolidated)”
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction) Partial Correction of “Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2025 [Japan GAAP] (Consolidated)”
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction: Numerical Data Correction) Partial Correction of “2025 March Fiscal Year Q3 Financial Summary [Japanese GAAP] (Consolidated)”
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction: Numerical Data Correction) Partial Correction Regarding the “Financial Summary for the Fiscal Year Ending March 2025 [Japanese GAAP] (Consolidated)”
|
Mar 5, 2026
|
| 7173 |
Tokyo Kiraboshi Financial Group, Inc.
|
Other |
|
(Correction: Numerical Data Revision) Partial Correction of the “Financial Summary for the First Quarter of Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)”
|
Mar 5, 2026
|
